Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Exagen Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 57 | 54 | −3 |
| Shares | 8.95M | 8.61M | −332.8K (−3.7%) |
| Value | $156.3M | $129.2M | −$27.1M (−17.4%) |
New holders (8)
Institutions that held Exagen Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Brinker Capital Investments, LLC | 120,239 | $1.80M | 0.02% |
| Millennium Management LLC | 76,058 | $1.14M | 0.00% |
| EMC Capital Management | 32,447 | $486.0K | 0.28% |
| Dimensional Fund Advisors LP | 14,160 | $212.0K | 0.00% |
| Walleye Capital LLC | 12,398 | $186.0K | 0.01% |
| Goldman Sachs Group Inc | 10,189 | $153.0K | 0.00% |
| First Horizon Corp | 958 | $14.0K | 0.00% |
| Captrust Financial Advisors | 340 | $5.00K | 0.00% |
Sold out (11)
Institutions that held Exagen Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Parian Global Management LP | 192,368 | $3.37M |
| Monashee Investment Management LLC | 172,170 | $3.01M |
| Eversept Partners, LP | 104,437 | $1.83M |
| Alyeska Investment Group, L.P. | 102,231 | $1.79M |
| Altium Capital Management LP | 86,475 | $1.51M |
| CVI Holdings, LLC | 72,952 | $1.28M |
| Davidson Kempner Capital Management LP | 40,951 | $707.0K |
| Laurion Capital Management LP | 30,000 | $525.0K |
| Caas Capital Management LP | 24,349 | $426.0K |
| Lazard Asset Management LLC | 913 | $15.0K |
| Total Clarity Wealth Management, Inc. | 378 | $7.00K |